Despite the limited availability of treatment for Spinal Muscular Atrophy (SMA) due to high costs, a boy from West Bengal was successfully administered this life-saving drug.

Gene therapy for Spinal Muscular Atrophy (SMA) is prohibitively expensive in India, with the life-saving drug Zolgensma priced at 16 crore rupees.Only a few children have managed to access treatment...